not a stock to be out of!

I’ve been heavily invested in TIS for the past 8 years and have never once given up on management or the product. I believe we are getting very close to pay day and all shareholders will be rewarded much more than you could ever imagine.

I feel yesterdays buying was most likely just a few new investors buying in after the write in the FIN over the weekend.

If TIS decide to bring in a large US partner to fund the FDA trial we may not need a capital raising as planned. ACR has been very successful in partnering with Eli Lilly and I could see this working well for us too.

DYOR